With scholarly social network ResearchGate now adding 10,000 users a day to its network of 4.5 million researchers, the idea of a "Facebook for science" has finally taken off. But these numbers say nothing about whether people actually use the site and why, a shortcoming Nature has tried to fix by surveying thousands of researchers about their social media habits.
Less than one year has passed since a $760,000, Mark Cuban-backed seed round put Validic on the map, but the firm and its health data aggregation platform have come a long way in the intervening months. And with Validic's scale and ambition growing, the company has raised $5 million in first round funding.
Calico, Google's first major foray into biotech, has been quietly filling its ranks and fleshing out its mission in the months since its existence first came to light, bringing together industry luminaries to tackle the broad issue of aging.
The website for Google's antiaging startup Calico has gone live, but details of the venture remain scarce.
Over the past year, many tech heavyweights have begun moving into the mHealth sector. Developers got an early look at Google's offering this week, with the search giant releasing a preview version of its APIs for health app developers.
Google released a preview of its software development kit for fitness apps on Aug. 7. The software will interact with wearable devices and enable a variety of apps to benefit from information about a user's fitness history stored on a centralized interface.
Venter has gone to Mountain View to make his latest hire, nabbing Franz Och to build a Google Translate for genomics.
The challenge calls on competitors to create the most accurate algorithms for detecting Single Nucleotide Variants (SNVs) and Structural Variations (SVs).
Google isn't just searching the Internet. The company will soon search the insides of people's bodies for new biomarkers by collecting their urine, blood, saliva and tears as part of its Baseline Study initiative.
Patients should have the option to take more risks when seeking medical treatment, said Dr. Kevin Tracey in a Wall Street Journal column.